Cost-effectiveness of combining finerenone and sodium-glucose cotransporter 2 inhibitors with standard of care for patients with chronic kidney disease and type 2 diabetes in China. - Hu, Zhengqiang; Jin, Wei; Lou, Shengying; Zhang, Lejun (Renal Failure, 2025)